Nat Struct Mol Biol:钠在大脑中发挥着独特的重要作用

2013-09-09 冯卫东 中国科技网

9月5日加拿大研究人员发现,盐的主要化学成分——钠,是大脑中重要神经递质——红藻氨酸受体的一个独特“开关”。红藻氨酸受体是大脑正常功能的基础,与癫痫症和神经性疼痛等多种疾病相关。【原文下载】 麦吉尔大学药理学和药物治疗学系教授德里克·鲍伊的此项发现,为大脑如何传输信息提供了不同的观点。该项研究的重点在于开发药物的新靶点,研究结果发表在《自然·结构和分子生物学》杂志上。 红藻氨酸受体活性的平

9月5日加拿大研究人员发现,盐的主要化学成分——钠,是大脑中重要神经递质——红藻氨酸受体的一个独特“开关”。红藻氨酸受体是大脑正常功能的基础,与癫痫症和神经性疼痛等多种疾病相关。【原文下载

麦吉尔大学药理学和药物治疗学系教授德里克·鲍伊的此项发现,为大脑如何传输信息提供了不同的观点。该项研究的重点在于开发药物的新靶点,研究结果发表在《自然·结构和分子生物学》杂志上。

红藻氨酸受体活性的平衡是维持正常脑功能的关键。例如,癫痫是红藻氨酸活性过度的结果。因此,设计出能关闭这些活性的药物将是非常有益的。

鲍伊教授表示,人们几十年来一直在推测所有大脑受体的开关应位于神经递质的结合部位。不过,新研究发现了一个可将单个钠原子进行结合的完全独立的位点,其能控制红藻氨酸受体何时打开和关闭。

所谓的药物“脱靶效应”是现代医学面临的最大挑战之一。钠开关对红藻氨酸受体具有独特性,意味着设计出旨在刺激这个开关的药物,不会在大脑中的其他地方起作用。这将是药物设计的重大进步,因为现有药物除了会在目标位点产生作用,往往还会影响许多其他位点,从而产生副作用。

圈点

食盐是人们膳食中最常用的调味品,也是人体中不可或缺的物质成分。如今,其主要化学成分钠还被发现有助开发药物的新靶点,更让人对它刮目相看。射击赛场上的脱靶,顶多让运动员极其懊恼罢了,而医学上的药物“脱靶”,所产生的副作用却难以估量。文中的新发现,就好比帮药物找到了精准“打击”病症的小窍门,这对减轻患者无谓的病痛无疑大有裨益。受此启发,更加精确的药物靶点或将呼之欲出。(生物谷Bioon.com)

生物谷推荐的英文摘要

cover image

Nature Structural & Molecular Biology doi:10.1038/nsmb.2654

Defining the structural relationship between kainate-receptor deactivation and desensitization

G Brent Dawe,  Maria Musgaard,  Elizabeth D Andrews,  Bryan A Daniels,  Mark R P Aurousseau,  Philip C Biggin  & Derek Bowie

Desensitization is an important mechanism curtailing the activity of ligand-gated ion channels (LGICs). Although the structural basis of desensitization is not fully resolved, it is thought to be governed by physicochemical properties of bound ligands. Here, we show the importance of an allosteric cation-binding pocket in controlling transitions between activated and desensitized states of rat kainate-type (KAR) ionotropic glutamate receptors (iGluRs). Tethering a positive charge to this pocket sustains KAR activation, preventing desensitization, whereas mutations that disrupt cation binding eliminate channel gating. These different outcomes explain the structural distinction between deactivation and desensitization. Deactivation occurs when the ligand unbinds before the cation, whereas desensitization proceeds if a ligand is bound without cation pocket occupancy. This sequence of events is absent from AMPA-type iGluRs; thus, cations are identified as gatekeepers of KAR gating, a role unique among even closely related LGICs.

原文下载

Dawe GB, Musgaard M, Andrews ED, Daniels BA, Aurousseau MR, Biggin PC, Bowie D.Defining the structural relationship between kainate-receptor deactivation and desensitization.Nat Struct Mol Biol. 2013 Sep;20(9):1054-61.

 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2023458, encodeId=7acc2023458b7, content=<a href='/topic/show?id=57ce9605ef6' target=_blank style='color:#2F92EE;'>#重要作用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96057, encryptionId=57ce9605ef6, topicName=重要作用)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e4c53, createdName=jiyangfei, createdTime=Thu Oct 03 06:05:00 CST 2013, time=2013-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1766840, encodeId=62f31e668404f, content=<a href='/topic/show?id=64f5343e2f' target=_blank style='color:#2F92EE;'>#Biol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3437, encryptionId=64f5343e2f, topicName=Biol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=446937890434, createdName=12498ebem31暂无昵称, createdTime=Mon Oct 14 08:05:00 CST 2013, time=2013-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1916981, encodeId=0c351916981dc, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Thu Feb 13 14:05:00 CST 2014, time=2014-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1795121, encodeId=fdce1e95121d7, content=<a href='/topic/show?id=1c9f16846fe' target=_blank style='color:#2F92EE;'>#Struc#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16846, encryptionId=1c9f16846fe, topicName=Struc)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4a4d285, createdName=日月, createdTime=Sat Oct 12 01:05:00 CST 2013, time=2013-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1879664, encodeId=f13218e966495, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Mon Apr 28 21:05:00 CST 2014, time=2014-04-28, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2023458, encodeId=7acc2023458b7, content=<a href='/topic/show?id=57ce9605ef6' target=_blank style='color:#2F92EE;'>#重要作用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96057, encryptionId=57ce9605ef6, topicName=重要作用)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e4c53, createdName=jiyangfei, createdTime=Thu Oct 03 06:05:00 CST 2013, time=2013-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1766840, encodeId=62f31e668404f, content=<a href='/topic/show?id=64f5343e2f' target=_blank style='color:#2F92EE;'>#Biol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3437, encryptionId=64f5343e2f, topicName=Biol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=446937890434, createdName=12498ebem31暂无昵称, createdTime=Mon Oct 14 08:05:00 CST 2013, time=2013-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1916981, encodeId=0c351916981dc, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Thu Feb 13 14:05:00 CST 2014, time=2014-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1795121, encodeId=fdce1e95121d7, content=<a href='/topic/show?id=1c9f16846fe' target=_blank style='color:#2F92EE;'>#Struc#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16846, encryptionId=1c9f16846fe, topicName=Struc)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4a4d285, createdName=日月, createdTime=Sat Oct 12 01:05:00 CST 2013, time=2013-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1879664, encodeId=f13218e966495, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Mon Apr 28 21:05:00 CST 2014, time=2014-04-28, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2023458, encodeId=7acc2023458b7, content=<a href='/topic/show?id=57ce9605ef6' target=_blank style='color:#2F92EE;'>#重要作用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96057, encryptionId=57ce9605ef6, topicName=重要作用)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e4c53, createdName=jiyangfei, createdTime=Thu Oct 03 06:05:00 CST 2013, time=2013-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1766840, encodeId=62f31e668404f, content=<a href='/topic/show?id=64f5343e2f' target=_blank style='color:#2F92EE;'>#Biol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3437, encryptionId=64f5343e2f, topicName=Biol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=446937890434, createdName=12498ebem31暂无昵称, createdTime=Mon Oct 14 08:05:00 CST 2013, time=2013-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1916981, encodeId=0c351916981dc, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Thu Feb 13 14:05:00 CST 2014, time=2014-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1795121, encodeId=fdce1e95121d7, content=<a href='/topic/show?id=1c9f16846fe' target=_blank style='color:#2F92EE;'>#Struc#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16846, encryptionId=1c9f16846fe, topicName=Struc)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4a4d285, createdName=日月, createdTime=Sat Oct 12 01:05:00 CST 2013, time=2013-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1879664, encodeId=f13218e966495, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Mon Apr 28 21:05:00 CST 2014, time=2014-04-28, status=1, ipAttribution=)]
    2014-02-13 sunylz
  4. [GetPortalCommentsPageByObjectIdResponse(id=2023458, encodeId=7acc2023458b7, content=<a href='/topic/show?id=57ce9605ef6' target=_blank style='color:#2F92EE;'>#重要作用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96057, encryptionId=57ce9605ef6, topicName=重要作用)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e4c53, createdName=jiyangfei, createdTime=Thu Oct 03 06:05:00 CST 2013, time=2013-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1766840, encodeId=62f31e668404f, content=<a href='/topic/show?id=64f5343e2f' target=_blank style='color:#2F92EE;'>#Biol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3437, encryptionId=64f5343e2f, topicName=Biol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=446937890434, createdName=12498ebem31暂无昵称, createdTime=Mon Oct 14 08:05:00 CST 2013, time=2013-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1916981, encodeId=0c351916981dc, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Thu Feb 13 14:05:00 CST 2014, time=2014-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1795121, encodeId=fdce1e95121d7, content=<a href='/topic/show?id=1c9f16846fe' target=_blank style='color:#2F92EE;'>#Struc#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16846, encryptionId=1c9f16846fe, topicName=Struc)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4a4d285, createdName=日月, createdTime=Sat Oct 12 01:05:00 CST 2013, time=2013-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1879664, encodeId=f13218e966495, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Mon Apr 28 21:05:00 CST 2014, time=2014-04-28, status=1, ipAttribution=)]
    2013-10-12 日月
  5. [GetPortalCommentsPageByObjectIdResponse(id=2023458, encodeId=7acc2023458b7, content=<a href='/topic/show?id=57ce9605ef6' target=_blank style='color:#2F92EE;'>#重要作用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96057, encryptionId=57ce9605ef6, topicName=重要作用)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e4c53, createdName=jiyangfei, createdTime=Thu Oct 03 06:05:00 CST 2013, time=2013-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1766840, encodeId=62f31e668404f, content=<a href='/topic/show?id=64f5343e2f' target=_blank style='color:#2F92EE;'>#Biol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3437, encryptionId=64f5343e2f, topicName=Biol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=446937890434, createdName=12498ebem31暂无昵称, createdTime=Mon Oct 14 08:05:00 CST 2013, time=2013-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1916981, encodeId=0c351916981dc, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Thu Feb 13 14:05:00 CST 2014, time=2014-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1795121, encodeId=fdce1e95121d7, content=<a href='/topic/show?id=1c9f16846fe' target=_blank style='color:#2F92EE;'>#Struc#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16846, encryptionId=1c9f16846fe, topicName=Struc)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4a4d285, createdName=日月, createdTime=Sat Oct 12 01:05:00 CST 2013, time=2013-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1879664, encodeId=f13218e966495, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Mon Apr 28 21:05:00 CST 2014, time=2014-04-28, status=1, ipAttribution=)]
    2014-04-28 liye789132251

相关资讯

Neuroscience:脊髓损伤小鼠的免疫功能被成功恢复

据物理学家组织网8月7日(北京时间)报道,美国俄亥俄州立大学维克斯纳医疗中心脑和脊髓修复中心的研究人员开展的一项最新研究显示,脊髓损伤小鼠的免疫功能有可能得到恢复。该结果已经发表在《神经科学》杂志上。 脊髓损伤的人往往免疫功能也受到损伤,这使他们更易被感染。这些人的免疫力遭到抑制的原因不明,但这项新研究发现,一种被称为自主神经反射异常的疾病可以引起免疫抑制。 自主神经反射异常是高位脊髓损伤患者

Neuron:研究发现多巴胺与记忆力密切相关

多巴胺是一种神经递质,脑内多巴胺缺乏,就会出现震颤、僵直、运动迟缓等帕金森氏症症状。 现在日本京都大学等机构的研究人员发现,多巴胺不仅会影响身体活动性,对于记忆力也发挥着重要作用。相关研究论文在线刊登在了近期出版的《神经元》杂志上。【原文下载】 研究人员表示,这一研究成果部分解释了为何帕金森氏症患者及抑郁症患者常会并发认知障碍,这将有助于对患者开展治疗。 在这项研究中,科

STM:大脑的复杂性提供了有关意识的线索

意识是难以捉摸的,但我们知道它就是那个当我们进入深度睡眠时会消失而当我们醒来时会重新出现的东西。医生们常常会通过人们是否有能力对外部指令——如“睁开你的眼睛”,或“捏我的手”——进行处理并做出回应来决定一个人是否有意识。但这些方法都是肤浅的,因为在过去10年中的研究已经证明一个完全与外部环境隔绝联系的大脑仍然可以有某种程度的意识,这种情况也会发生在从昏迷中恢复但却无法移动或理解命令的脑部受伤的

精神疾病**诊断方法 血液测试或可预测自杀倾向

以色列贝尔谢巴精神卫生中心的研究人员发现,精神疾病自杀患者血小板数量比非自杀患者明显高,这项开创性的研究为用简单的血液测试来预测一个精神病患者的自杀倾向提供了可能。 人体的其他疾病一般可通过血液或其他生物标记识别,但至今为止,大多数精神疾病的评估,只能通过耐心的观察,它要求精神科医生或相关的医疗从业者长期跟踪检查病人的行为和其他外部症状,以确定病人是精神分裂、抑郁或双向情感障碍等。这在医学界一直

Nat Commun:与习惯性行动有关的脑区域

本期Nature Communications上发表的一篇研究论文描述了负责在啮齿类动物的习惯性行动和目标性行动之间切换的神经过程。这些发现让我们对大脑处理现实中日常情况的连线方式有了新认识,同时也有可能提供有关在“强迫症”等疾病中被扰乱的系统的信息。【原文下载】 所有动物都不断会碰到需要对其行动的后果进行内部评估的情况,重要的是它们能够在习惯性行动和目标性行动之间进行切换。虽然主管目标性或习惯

Nat Neurosci:上海交大自身免疫性脑脊髓炎新成果

来自上海交通大学医学院、美国克利夫兰诊所(Cleveland Clinic)的研究人员,在新研究中证实在NG2+神经胶质细胞中的Act1选择性介导了IL-17诱导的实验性自身免疫性脑脊髓炎(EAE)发病。这一研究发现在线发表在9月1日的《自然神经科学》(Nature Neuroscience)杂志上。【原文下载】 论文的通讯作者是美国克利夫兰诊所的李晓霞(Xiaoxia Li,音译)博士